Outset Medical, Inc., a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced that members of management will participate in fireside chats at two upcoming investor conferences.
Event: 2022 UBS Global Healthcare Conference
Date: Tuesday, May 24, 2022
Time: 4:45am PT / 7:45am ET
Event: Goldman Sachs 43rd Annual Global Healthcare Conference
Date: Tuesday, June 14, 2022
Time: 3:20pm PT / 6:20pm ET
A live and archived webcast of the fireside chats will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220518005744/en/
Jim Mazzola
Vice President, Investor Relations
jmazzola@outsetmedical.com
Brian Johnston
Gilmartin Group
(332) 895-3222
investors@outsetmedical.com
Source: Outset Medical, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20220518005744/en
